MedTrace Logo

SYSTANE® Family - Meibomian Deficiency

NCT01733745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2018-06-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to assess the efficacy of the SYSTANE® family of products (SYSTANE® Lid Wipes, SYSTANE® BALANCE Lubricant Eye Drops, and SYSTANE® Vitamins) on meibomian gland functionality in subjects with lipid deficiency related to evaporative dry eye as compared to the standard of care warm compresses.

Conditions

  • Dry Eye Syndrome

Interventions

OTHER

SYSTANE® Lid Wipes

Pre-moistened eyelid cleansing wipes for topical ocular external scrubbing of eyelids and eyelashes

OTHER

SYSTANE® BALANCE

Lubricant Eye Drops

DIETARY_SUPPLEMENT

SYSTANE® Vitamins

OTHER

Microfiber towels (as warm compresses, with or without saline eye drops)

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Danyel C. Carr, MS, CCRA · Alcon Research

  • Donald R Korb, O.D. · Korb and Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-06-30
Completion
2013-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01733745 on ClinicalTrials.gov